EditorialThe “inactivity trap”☆
References (23)
- et al.
A single dose of the serotonin neurotransmission agonist paroxetine enhances motor output: double-blind, placebo-controlled, fMRI study in healthy subjects
Neuroimage
(2002) - et al.
Modulation of behavior and cortical motor activity in healthy subjects by a chronic administration of a serotonin enhancer
Neuroimage
(2005) - et al.
Depression as an evolutionary adaptation: implications for the development of preclinical models
Med Hypotheses
(2009) Depression in hospitalized older patients with congestive heart failure
Gen Hosp Psychiatry
(1998)Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability
Gen Hosp Psychiatry
(2007)- et al.
Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study
J Am Coll Cardiol
(2009) - et al.
Physical activity and likelihood of depression in adults: a review
Prev Med
(2008) - et al.
Fluoxetine modulates motor performance and cerebral activation of patients recovering from stroke
Ann Neurol
(2001) - et al.
Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions
Arch Gen Psychiatry
(2005) - et al.
Prevalence of depression in hospitalized patients with congestive heart failure
Psychosom Med
(2003)
Prevalence of depression in patients with cancer
J Natl Cancer Inst Monogr
Cited by (10)
Is behavioral activation an effective and acceptable treatment for co-occurring depression and substance use disorders? A meta-analysis of randomized controlled trials
2022, Journal of Substance Abuse TreatmentCitation Excerpt :BA is based on behavior modification and reinforcement theory (e.g. (Lewinsohn & Shaffer, 1971), which posits that depression develops when people have reduced access to contingent reward from their environment for non-depressive and functional behaviors. The typical depressive behavioral responses (e.g., avoidance and inactivity) then contribute to the maintenance of low mood, leading to what has been termed the “inactivity trap” (Elfrey & Ziegelstein, 2009). SUDs and depression are therefore maintained through the interaction of both positive (i.e., the positive feeling created by the substance) and negative (i.e., escaping or avoiding negative feelings, experiences or thoughts) reinforcement schedules.
Living with multiple losses: Insights from patients living with pressure injury
2018, CollegianCitation Excerpt :Patients report pain, malodour and exudate, social isolation, reduced independence and reduced mobility (Fox, 2002; Langemo, Melland, Hanson, Olson, & Hunter, 2000) all of which delay rehabilitation and impact both on patients and their families (Hopkins, Dealey, Bale, Defloor, & Worboys, 2006). Reduced physical activity and depression stemming from PI are inextricably linked and have been referred to as the ‘inactivity trap’ (Elfrey & Ziegelstein, 2009). Combined with advanced age, malnourishment and co-morbidities, PIs can make it difficult for people to partake in their usual activities, both within and outside their homes (Gallagher et al., 2008).
A longitudinal community study of major depression and physical activity
2009, General Hospital PsychiatryCitation Excerpt :The association between depression and physical inactivity is potentially bidirectional with physical inactivity leading to depression and depression leading to physical inactivity. Elfrey and Ziegelstein [1] have used the phrase “inactivity trap” to describe this dynamic. The possibility that physical activity may prevent depression or reduce levels of depressive symptoms has been the focus of many recent studies.
Using photovoice to understand and improve healthy lifestyles of people diagnosed with serious mental illness
2022, Journal of Psychiatric and Mental Health NursingAssociations between mental distress and physical activity in US adults: A dose-response analysis BRFSS 2011
2018, Journal of Public Health (United Kingdom)
- ☆
Dr. Ziegelstein is supported by grant number R24AT004641 from the National Center for Complementary & Alternative Medicine and by the Miller Family Scholar Program of the Johns Hopkins Center for Innovative Medicine.